(A) Image of Rothia mucilaginosa grown on a blood agar plate showing mucoid, grayish colonies after incubation at 37℃ for 48 hr. (B) Microscopic image of the cultured isolates showing clusters of gram-positive cocci (Gram stain, ×1,000).
Researchers have isolated an enzyme from bacteria present in human saliva that has potential as a therapy for celiac disease (CD). An estimated 3 million people in the U.S. have celiac disease. Currently, the main course of treatment for people with CD is adherence to a strict gluten-free diet. “Gluten are proline- and glutamine-rich proteins present in wheat, barley and rye, and contain the immunogenic sequences that drive celiac disease (CD),” the researchers wrote...
Read More
Recent Comments